Beam Therapeutics (BEAM) Return on Equity (2019 - 2025)
Historic Return on Equity for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to 0.41%.
- Beam Therapeutics' Return on Equity fell 2500.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of 0.44% for FY2024, which is 2800.0% down from last year.
- According to the latest figures from Q3 2025, Beam Therapeutics' Return on Equity is 0.41%, which was down 2500.0% from 0.37% recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Return on Equity ranged from a high of 0.14% in Q1 2024 and a low of 0.91% during Q1 2021
- In the last 5 years, Beam Therapeutics' Return on Equity had a median value of 0.38% in 2023 and averaged 0.38%.
- In the last 5 years, Beam Therapeutics' Return on Equity surged by 20100bps in 2021 and then crashed by -3400bps in 2024.
- Over the past 5 years, Beam Therapeutics' Return on Equity (Quarter) stood at 0.42% in 2021, then rose by 8bps to 0.38% in 2022, then skyrocketed by 63bps to 0.14% in 2023, then plummeted by -242bps to 0.49% in 2024, then increased by 15bps to 0.41% in 2025.
- Its Return on Equity was 0.41% in Q3 2025, compared to 0.37% in Q2 2025 and 0.42% in Q1 2025.